Last updated on April 18, 2014 at 21:21 EDT

Latest PhytoMedical Stories

2008-08-11 09:01:39

PhytoMedical Technologies, Inc. (OTCBB:PYTO) (FWB:ET6), today announced that it has entered into an exclusive worldwide license agreement with Dartmouth College to develop, market and distribute new anti-tumor bis-acridines, bis-ellipticines and bis-carbazoles known as intercalating agents developed by leading researcher, Dr. Gordon Gribble, of Dartmouth College. Under terms of the agreement, PhytoMedical agreed to pay an undisclosed license fee and milestone payments to Dartmouth. The...